HS2 Ltd today launched Florence, the first of 10 tunnel boring machines that will dig 64 miles of tunnels between London and the West Midlands. Named after Florence Nightingale the 170m long TBM will dig the first of a pair of 10-mile long tunnels under the Chiltern Hills. A second machine Cecilia ...

https://www.theengineer.co.uk/hs2-florence-tunnel-boring-machine-tbm-chiltern/

#TheEngineer

Farmers should avoid rushing into carbon offsetting deals until there is greater transparency and regulations in the market place, NFU deputy president Stuart Roberts has warned...

https://www.fginsight.com/news/news/farmers-must-exercise-caution-with-carbon-offsetting-deals-119244

#FGInsightNews

The pre-filter was developed by Hengst Filtration and the development of the housing was a joint effort between Hengst and TBH.Hengst Filtration, in partnership with German extraction systems’ specialist, TBH, has developed the InLine patient filter, a pre-filter for extraction systems to ...

https://www.filtsep.com:443/filter media/news/hengst-develops-prefilter-for-extraction-systems/

The Burberry Group plc (BRBY:LSE) share price has fallen 10% in early trading but this Fool thinks the company remains a great pick for the long term.
The post The Burberry share price (BRBY) has tumbled. Heres why Id buy now appeared first on The Motley Fool UK.

The share price FTSE 100 luxury ...

https://www.fool.co.uk/investing/2021/05/13/the-burberry-share-price-brby-has-tumbled-heres-why-id-buy-now/

#TheMotleyFoolUK

In a report released yesterday, Robert Hazlett from BTIG reiterated a Buy rating on Syndax Pharmaceuticals (SNDX), with a price target of $32.00.
The post Syndax Pharmaceuticals (SNDX) Gets a Buy Rating from BTIG appeared first on Smarter Analyst.
In a report released yesterday, Robert Hazlett from ...

https://www.smarteranalyst.com/new-blurbs/syndax-pharmaceuticals-sndx-gets-a-buy-rating-from-btig/

#SmarterAnalyst

In a report released yesterday, Sung Ji Nam from BTIG maintained a Hold rating on Fulgent Genetics (FLGT). The companys shares closed last ...
The post Fulgent Genetics (FLGT) Gets a Hold Rating from BTIG appeared first on Smarter Analyst.
In a report released yesterday, Sung Ji Nam from BTIG ...

https://www.smarteranalyst.com/new-blurbs/fulgent-genetics-flgt-gets-a-hold-rating-from-btig/

#SmarterAnalyst

BTIG analyst Timothy P. Hayes reiterated a Hold rating on Broadmark Realty Capital (BRMK) on May 11.
The post BTIG Sticks to Their Hold Rating for Broadmark Realty Capital (BRMK) appeared first on Smarter Analyst.
BTIG analyst Timothy P. Hayes reiterated a Hold rating on Broadmark Realty Capital (...

https://www.smarteranalyst.com/new-blurbs/btig-sticks-to-their-hold-rating-for-broadmark-realty-capital-brmk/

#SmarterAnalyst

In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on Exagen (XGN), with a price target of $23.00.
The post Exagen (XGN) Gets a Buy Rating from BTIG appeared first on Smarter Analyst.
In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on Exagen...

https://www.smarteranalyst.com/new-blurbs/exagen-xgn-gets-a-buy-rating-from-btig/

#SmarterAnalyst

In a report issued on May 11, Robert Hazlett from BTIG maintained a Buy rating on Galera Therapeutics (GRTX), with a price target ...
The post BTIG Thinks Galera Therapeutics Stock is Going to Recover appeared first on Smarter Analyst.
In a report issued on May 11, Robert Hazlett from BTIG ...

https://www.smarteranalyst.com/new-blurbs/btig-thinks-galera-therapeutics-stock-is-going-to-recover-2/

#SmarterAnalyst

BTIG analyst David Larsen maintained a Hold rating on 1Life Healthcare (ONEM) today. The companys shares closed last Wednesday at $38.
The post 1Life Healthcare (ONEM) Receives a Hold from BTIG appeared first on Smarter Analyst.
BTIG analyst David Larsen maintained a Hold rating on 1Life Healthcare...

https://www.smarteranalyst.com/new-blurbs/1life-healthcare-onem-receives-a-hold-from-btig/

#SmarterAnalyst

In a report issued on May 11, David Larsen from BTIG maintained a Hold rating on Oak Street Health (OSH). The companys shares ...
The post BTIG Maintains a Hold Rating on Oak Street Health (OSH) appeared first on Smarter Analyst.
In a report issued on May 11, David Larsen from BTIG maintained a Hold...

https://www.smarteranalyst.com/new-blurbs/btig-maintains-a-hold-rating-on-oak-street-health-osh/

#SmarterAnalyst

BTIG analyst Jake Fuller maintained a Hold rating on Opendoor Technologies (OPEN) on May 11. The companys shares closed last Wednesday at $15.
The post Opendoor Technologies (OPEN) Receives a Hold from BTIG appeared first on Smarter Analyst.
BTIG analyst Jake Fuller maintained a Hold rating on ...

https://www.smarteranalyst.com/new-blurbs/opendoor-technologies-open-receives-a-hold-from-btig/

#SmarterAnalyst

BTIG analyst David Larsen reiterated a Hold rating on American Well (AMWL) yesterday. The companys shares closed last Wednesday at $12.
The post American Well (AMWL) Receives a Hold from BTIG appeared first on Smarter Analyst.
BTIG analyst David Larsen reiterated a Hold rating on American Well (AMWL...

https://www.smarteranalyst.com/new-blurbs/american-well-amwl-receives-a-hold-from-btig/

#SmarterAnalyst

BTIG analyst Sung Ji Nam maintained a Buy rating on Biodesix (BDSX) yesterday and set a price target of $28.00.
The post BTIG Thinks Biodesixs Stock is Going to Recover appeared first on Smarter Analyst.
BTIG analyst Sung Ji Nam maintained a Buy rating on Biodesix (BDSX) yesterday and set a price ...

https://www.smarteranalyst.com/new-blurbs/btig-thinks-biodesixs-stock-is-going-to-recover/

#SmarterAnalyst

In a report issued on May 11, Thomas Shrader from BTIG maintained a Buy rating on SQZ Biotechnologies (SQZ), with a price target ...
The post BTIG Keeps a Buy Rating on SQZ Biotechnologies (SQZ) appeared first on Smarter Analyst.
In a report issued on May 11, Thomas Shrader from BTIG maintained a ...

https://www.smarteranalyst.com/new-blurbs/btig-keeps-a-buy-rating-on-sqz-biotechnologies-sqz/

#SmarterAnalyst

We're going to tell a story with a single chart today. We've compared Arizona's first wave trough with its second wave trough in the following chart, where we've estimated the number of excess COVID cases Arizona has counted as a result of the Biden-Harris administration's border migration crisis. ...

https://politicalcalculations.blogspot.com/2021/05/increase-in-arizona-covid-cases-from.html

#PoliticalCalculations

In todays Global Bulletin, the English Premier League renews rights deals for three years; Stephen Graham-starrer Boiling Point sells wide; and NENT Group sets terrorism drama Red Election. The English Premier League soccer championship has agreed a proposal for a ...

https://variety.com/2021/tv/global/english-premier-league-rights-deal-sky-amazon-bt-bbc-1234972109/

#variety

Historically overlooked by buyers, diverse audiences---and the networks they watch---are no longer an optional,--"nice to have" ad strategy component...

https://adage.com/article/special-report-tv-upfront/5-multicultural-media-brands-watch-during-2021-upfront-season/2332901

#adage

Ad volumes for FMCG in April 2021 grew by 166% when compared to 2020...

https://www.financialexpress.com/brandwagon/television-ad-volumes-rose-by-39-during-january-to-april-2021-barc/2251249/

#TheFinancialExpress

Redmi Note 10S India price starts at Rs 14,999 while Redmi Watch will be available for Rs 3,999...

https://www.financialexpress.com/industry/technology/redmi-note-10s-redmi-watch-launched-in-india-specs-features-price-and-everything-to-know/2251245/

#financialexpress

More Senior Bankers Are Abandoning London In Favor Of Europe

Earlier, we noted how French officials are planning to sabotage talks between the UK and the EU about expanding access to EU financial markets. At this point, even if Britain does manage to make progress with the EU in a meeting later ...

https://www.zerohedge.com/markets/more-senior-bankers-are-abandoning-london-favor-europe

#ZeroHedge

Aim-listed Caledonia Mining recorded gross revenues of $25.7-million for the quarter ended March 31, with higher revenues year-on-year reflecting a higher realised gold price, offset by lower sales as a result of lower production. Revenues include the sales proceeds of 1 584 oz of gold in work-in-...

http://www.miningweekly.com/article/caledonias-lower-quarterly-production-offset-by-gold-price-2021-05-13

#MiningWeeklyGold

Vancouver-headquartered Barksdale Resources on Wednesday announced that it would acquire two copper exploration projects in Santa Cruz, Arizona, from Kennecott Exploration and, in a separate transaction with Regal Resources, that it would consolidate a 100% interest in the nearby Sunnyside project...

http://www.miningweekly.com/article/barksdale-buys-arizona-projects-from-rio-tinto-2021-05-13

#MiningWeeklyNorthAmerica

Theres a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Computer Programs and Systems (CPSI), ...
The post Analysts Offer Insights on Technology Companies: Computer Programs and Systems (CPSI), Lattice Semicon (LSCC) and Mimecast (MIME) appeared first on Smarter...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-technology-companies-computer-programs-and-systems-cpsi-lattice-semicon-lscc-and-mimecast-mime/

#SmarterAnalyst

The self-proclaimed "Technoking" had only recently agreed with Twitter boss Jack Dorsey, saying bitcoin "incentivizes" renewable energy.

Tesla CEO, Elon Musk.
Win McNamee/Getty Images

Crypto fans decried Elon Musk's unexpected decision to halt bitcoin payments for Tesla cars.
Some argued bitcoin ...

https://www.businessinsider.com/elon-musk-bitcoin-tesla-crypto-bulls-challenge-environmental-concerns-payments-2021-5

#Insider

Leerink Partners analyst Danielle Antalffy maintained a Buy rating on Kellogg (K) on May 10. The companys shares closed last Wednesday at $66.
The post Leerink Partners Reaffirms Their Buy Rating on Kellogg (K) appeared first on Smarter Analyst.
Leerink Partners analyst Danielle Antalffy maintained...

https://www.smarteranalyst.com/new-blurbs/leerink-partners-reaffirms-their-buy-rating-on-kellogg-k/

#SmarterAnalyst

Leerink Partners analyst Marc Goodman maintained a Buy rating on Adamas Pharmaceuticals (ADMS) on May 10 and set a price target of $6.00.
The post Leerink Partners Keeps Their Buy Rating on Adamas Pharmaceuticals (ADMS) appeared first on Smarter Analyst.
Leerink Partners analyst Marc Goodman ...

https://www.smarteranalyst.com/new-blurbs/leerink-partners-keeps-their-buy-rating-on-adamas-pharmaceuticals-adms/

#SmarterAnalyst

In a report issued on May 10, Joseph Schwartz from Leerink Partners reiterated a Buy rating on Aurinia Pharmaceuticals (AUPH). The companys shares ...
The post Aurinia Pharmaceuticals (AUPH) Receives a Buy from Leerink Partners appeared first on Smarter Analyst.
In a report issued on May 10, Joseph ...

https://www.smarteranalyst.com/new-blurbs/aurinia-pharmaceuticals-auph-receives-a-buy-from-leerink-partners/

#SmarterAnalyst

Leerink Partners analyst Marc Goodman reiterated a Buy rating on Xenon (XENE) on May 11 and set a price target of $28.00.
The post Xenon (XENE) Gets a Buy Rating from Leerink Partners appeared first on Smarter Analyst.
Leerink Partners analyst Marc Goodman reiterated a Buy rating on Xenon (XENE) on ...

https://www.smarteranalyst.com/new-blurbs/xenon-xene-gets-a-buy-rating-from-leerink-partners/

#SmarterAnalyst

Leerink Partners analyst Joseph Schwartz maintained a Buy rating on Ascendis Pharma (ASND) on May 11. The companys shares closed last Wednesday at ...
The post Leerink Partners Maintains a Buy Rating on Ascendis Pharma (ASND) appeared first on Smarter Analyst.
Leerink Partners analyst Joseph ...

https://www.smarteranalyst.com/new-blurbs/leerink-partners-maintains-a-buy-rating-on-ascendis-pharma-asnd/

#SmarterAnalyst

CamCarb VG filters can be installed in specially designed housings, with options for front-loading, side loading, or positive seal side access (PSSA).Camfil’s CamCarb VG modules with loose-fill media are designed for the removal of corrosive, harmful and odorous contaminants from outdoor air ...

https://www.filtsep.com:443/filter media/news/camfil-offers-molecular-filtration-solution/

In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on Magenta Therapeutics (MGTA), with a price target of ...
The post Magenta Therapeutics (MGTA) Gets a Buy Rating from Mizuho Securities appeared first on Smarter Analyst.
In a report released today, Difei Yang ...

https://www.smarteranalyst.com/new-blurbs/magenta-therapeutics-mgta-gets-a-buy-rating-from-mizuho-securities/

#SmarterAnalyst

Leerink Partners analyst Joseph Schwartz maintained a Buy rating on Gossamer Bio (GOSS) on May 11 and set a price target of $19.00.
The post Leerink Partners Thinks Gossamer Bios Stock is Going to Recover appeared first on Smarter Analyst.
Leerink Partners analyst Joseph Schwartz maintained a Buy ...

https://www.smarteranalyst.com/new-blurbs/leerink-partners-thinks-gossamer-bios-stock-is-going-to-recover-2/

#SmarterAnalyst

Leerink Partners analyst Joseph Schwartz maintained a Buy rating on IMARA (IMRA) on May 11 and set a price target of $42.00.
The post Leerink Partners Thinks IMARAs Stock is Going to Recover appeared first on Smarter Analyst.
Leerink Partners analyst Joseph Schwartz maintained a Buy rating on IMARA...

https://www.smarteranalyst.com/new-blurbs/leerink-partners-thinks-imaras-stock-is-going-to-recover/

#SmarterAnalyst

Leerink Partners analyst Daina Graybosch maintained a Hold rating on Innate Pharma (IPHA) on May 11. The companys shares closed last Wednesday at ...
The post Leerink Partners Keeps Their Hold Rating on Innate Pharma (IPHA) appeared first on Smarter Analyst.
Leerink Partners analyst Daina Graybosch ...

https://www.smarteranalyst.com/new-blurbs/leerink-partners-keeps-their-hold-rating-on-innate-pharma-ipha/

#SmarterAnalyst

LONDON (AP) - The Premier League has been allowed by the British government to renew its current domestic television rights deals for another three seasons without an auction process, ensuring 5 billion pounds ($7 billion) will be generated during the uncertainty of the pandemic...

https://apnews.com/article/premier-league-europe-health-coronavirus-pandemic-soccer-c4743c24fa20edd7c66e0af4d9051553

#APNews

Theres a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on 8X8 (EGHT), Dynatrace (DT) and ...
The post Analysts Top Technology Picks: 8X8 (EGHT), Dynatrace (DT) appeared first on Smarter Analyst.
Theres a lot to be optimistic about in the Technology sector as 3 ...

https://www.smarteranalyst.com/new-blurbs/analysts-top-technology-picks-8x8-eght-dynatrace-dt/

#SmarterAnalyst

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Veracyte (VCYT), Akebia Therapeutics (AKBA) ...
The post Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Akebia Therapeutics (AKBA) and Minerva Neurosciences (NERV) appeared first on ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-veracyte-vcyt-akebia-therapeutics-akba-and-minerva-neurosciences-nerv/

#SmarterAnalyst

Read more on https://www.fxstreet.com...

https://www.fxstreet.com/cryptocurrencies/news/matic-price-prediction-polygon-sets-sights-on-new-all-time-high-despite-recent-flash-crash-202105130825

#FXStreetNews

BTIG analyst Peter Saleh maintained a Hold rating on Wendys (WEN) yesterday. The companys shares closed last Wednesday at $22.
The post BTIG Maintains Their Hold Rating on Wendys (WEN) appeared first on Smarter Analyst.
BTIG analyst Peter Saleh maintained a Hold rating on Wendys (WEN) yesterday. The...

https://www.smarteranalyst.com/new-blurbs/btig-maintains-their-hold-rating-on-wendys-wen/

#SmarterAnalyst

BTIG analyst Robert Hazlett maintained a Buy rating on Matinas BioPharma (MTNB) on May 11 and set a price target of $3.00.
The post BTIG Thinks Matinas BioPharmas Stock is Going to Recover appeared first on Smarter Analyst.
BTIG analyst Robert Hazlett maintained a Buy rating on Matinas BioPharma (...

https://www.smarteranalyst.com/new-blurbs/btig-thinks-matinas-biopharmas-stock-is-going-to-recover/

#SmarterAnalyst

Also: Why Rust in Android will use the Soong build system, not Cargo The Rust 2021 Edition Working Group has scheduled the new version for release in October, with what it says are small changes that amount to a significant improvement...

https://go.theregister.com/feed/www.theregister.com/2021/05/13/rust_2021_edition/

#TheRegister